SEARCH:   Advanced

Prepublished online as a Blood First Edition Paper on August 8, 2002; DOI 10.1182/blood-2002-05-1552. This Article Full Text Full Text (PDF) All Versions of this Article: 2002-05-1552v1 100/13/4660    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by BitMansour, A. Articles by Brown, J. M. Y. Search for Related Content PubMed PubMed Citation Articles by BitMansour, A. Articles by Brown, J. M. Y. Related Collections Transplantation Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 15 December 2002, Vol. 100, No. 13, pp. 4660-4667 TRANSPLANTATION Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation Andrew BitMansour, Stacy M. Burns, David Traver, Koichi Akashi, Christopher H. Contag, Irving L. Weissman, and Janice M. Y. Brown From the Divisions of Bone Marrow Transplantation and Infectious Diseases, Department of Medicine; Department of Pathology; and Departments of Pediatrics and Microbiology and Immunology; Stanford University School of Medicine, CA. Myelotoxic treatments for oncologic diseases are often complicated by neutropenia, which renders patients susceptible to potentially lethal infections. In these studies of murine hematopoietic stem cell transplantation (HSCT), cotransplantation of lineage-restricted progenitors known as common myeloid progenitors (CMP) and granulocyte-monocyte progenitors (GMP) protects against death following otherwise lethal challenge with either of 2 pathogens associated with neutropenia: Aspergillus fumigatus and Pseudomonas aeruginosa. Cotransplantation of CMP/GMP resulted in a significant and rapid increase in the absolute number of myeloid cells in the spleen, most of which were derived from the donor CMP/GMP. Despite persistent peripheral neutropenia, improved survival correlated with the measurable appearance of progenitor-derived myeloid cells in the spleen. A marked reduction or elimination of tissue pathogen load was confirmed by culture and correlated with survival. Localization of infection by P aeruginosa and extent of disease was also assessed by in vivo bioluminescent imaging using a strain of P aeruginosa engineered to constitutively express a bacterial luciferase. Imaging confirmed that transplantation with a graft containing hematopoietic stem cells and CMP/GMP reduced the bacterial load as early as 18 hours after infection. These results demonstrate that enhanced reconstitution of a tissue myeloid pool offers protection against lethal challenge with serious fungal and bacterial pathogens. © 2002 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: J. Domen, M. Wahedi, E. Danenberg, S. Smith-Berdan, J. Christensen, T. Fong, and J. Brown Neutropenic Mice Can Be Protected from Fungus Infection by Ex Vivo Expanded Allogeneic Myeloid Progenitors. Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 3038 - 3038. [Abstract] I. Weissman Stem Cell Research: Paths to Cancer Therapies and Regenerative Medicine JAMA, September 21, 2005; 294(11): 1359 - 1366. [Abstract] [Full Text] [PDF] S. Bellocchio, R. Gaziano, S. Bozza, G. Rossi, C. Montagnoli, K. Perruccio, M. Calvitti, L. Pitzurra, and L. Romani Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4 J. Antimicrob. Chemother., February 1, 2005; 55(2): 214 - 222. [Abstract] [Full Text] [PDF] R. Gaziano, S. Bozza, S. Bellocchio, K. Perruccio, C. Montagnoli, L. Pitzurra, G. Salvatori, R. De Santis, P. Carminati, A. Mantovani, et al. Anti-Aspergillus fumigatus Efficacy of Pentraxin 3 Alone and in Combination with Antifungals Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4414 - 4421. [Abstract] [Full Text] [PDF] L. Romani, F. Bistoni, R. Gaziano, S. Bozza, C. Montagnoli, K. Perruccio, L. Pitzurra, S. Bellocchio, A. Velardi, G. Rasi, et al. Thymosin {alpha} 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling Blood, June 1, 2004; 103(11): 4232 - 4239. [Abstract] [Full Text] [PDF] N. J. Chao, S. G. Emerson, and K. I. Weinberg Stem Cell Transplantation (Cord Blood Transplants) Hematology, January 1, 2004; 2004(1): 354 - 371. [Abstract] [Full Text] [PDF] J. R. Wingard, W. G. Nichols, and G. B. McDonald Supportive Care Hematology, January 1, 2004; 2004(1): 372 - 389. [Abstract] [Full Text] [PDF] S. Bozza, K. Perruccio, C. Montagnoli, R. Gaziano, S. Bellocchio, E. Burchielli, G. Nkwanyuo, L. Pitzurra, A. Velardi, and L. Romani A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation Blood, November 15, 2003; 102(10): 3807 - 3814. [Abstract] [Full Text] [PDF] C. Arber, A. BitMansour, T. E. Sparer, J. P. Higgins, E. S. Mocarski, I. L. Weissman, J. A. Shizuru, and J. M. Y. Brown Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation Blood, July 15, 2003; 102(2): 421 - 428. [Abstract] [Full Text] [PDF]

	Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020